The lowering of the price target from $9 to $7 by Barclays suggests a less optimistic view on the stock's potential, which could lead to a negative short-term impact on the stock price. The Equal-Weight rating indicates a neutral stance, but the reduced price target is likely to weigh on investor sentiment.